nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—Circadian rhythm sleep disorder—Varenicline—nicotine dependence	0.0523	0.119	CcSEcCtD
Topiramate—CA6—saliva—nicotine dependence	0.0266	0.166	CbGeAlD
Topiramate—Psychomotor skills impaired—Varenicline—nicotine dependence	0.0217	0.0493	CcSEcCtD
Topiramate—Terminal insomnia—Varenicline—nicotine dependence	0.0144	0.0328	CcSEcCtD
Topiramate—Bradyphrenia—Varenicline—nicotine dependence	0.0134	0.0304	CcSEcCtD
Topiramate—Middle insomnia—Varenicline—nicotine dependence	0.011	0.025	CcSEcCtD
Topiramate—Hypogeusia—Varenicline—nicotine dependence	0.0104	0.0237	CcSEcCtD
Topiramate—Initial insomnia—Varenicline—nicotine dependence	0.0099	0.0225	CcSEcCtD
Topiramate—Blindness transient—Varenicline—nicotine dependence	0.0099	0.0225	CcSEcCtD
Topiramate—Panic reaction—Varenicline—nicotine dependence	0.00901	0.0205	CcSEcCtD
Topiramate—GRIK5—midbrain—nicotine dependence	0.00889	0.0553	CbGeAlD
Topiramate—GRIK3—midbrain—nicotine dependence	0.00889	0.0553	CbGeAlD
Topiramate—GRIK1—midbrain—nicotine dependence	0.00845	0.0525	CbGeAlD
Topiramate—Mental retardation—Varenicline—nicotine dependence	0.00828	0.0188	CcSEcCtD
Topiramate—Myopia—Varenicline—nicotine dependence	0.00828	0.0188	CcSEcCtD
Topiramate—GRIA3—midbrain—nicotine dependence	0.00786	0.0488	CbGeAlD
Topiramate—Night blindness—Varenicline—nicotine dependence	0.00768	0.0174	CcSEcCtD
Topiramate—GRIK4—brain—nicotine dependence	0.00766	0.0476	CbGeAlD
Topiramate—GRIA4—brain—nicotine dependence	0.00605	0.0376	CbGeAlD
Topiramate—Sensory disturbance—Varenicline—nicotine dependence	0.00583	0.0133	CcSEcCtD
Topiramate—Polydipsia—Varenicline—nicotine dependence	0.00583	0.0133	CcSEcCtD
Topiramate—GRIK5—brain—nicotine dependence	0.00559	0.0347	CbGeAlD
Topiramate—GRIK3—brain—nicotine dependence	0.00559	0.0347	CbGeAlD
Topiramate—GRIK1—brain—nicotine dependence	0.00531	0.033	CbGeAlD
Topiramate—Anger—Varenicline—nicotine dependence	0.00506	0.0115	CcSEcCtD
Topiramate—GRIA3—brain—nicotine dependence	0.00494	0.0307	CbGeAlD
Topiramate—Abnormal behaviour—Varenicline—nicotine dependence	0.00486	0.011	CcSEcCtD
Topiramate—Musculoskeletal chest pain—Varenicline—nicotine dependence	0.00466	0.0106	CcSEcCtD
Topiramate—CA7—midbrain—nicotine dependence	0.00433	0.0269	CbGeAlD
Topiramate—GRIA1—midbrain—nicotine dependence	0.00419	0.0261	CbGeAlD
Topiramate—Depressed mood—Varenicline—nicotine dependence	0.00404	0.00919	CcSEcCtD
Topiramate—Pancreatitis acute—Varenicline—nicotine dependence	0.00392	0.0089	CcSEcCtD
Topiramate—Suicide—Varenicline—nicotine dependence	0.00349	0.00792	CcSEcCtD
Topiramate—GRIA2—midbrain—nicotine dependence	0.00333	0.0207	CbGeAlD
Topiramate—Balance disorder—Varenicline—nicotine dependence	0.00331	0.00751	CcSEcCtD
Topiramate—Urine abnormality—Varenicline—nicotine dependence	0.00327	0.00742	CcSEcCtD
Topiramate—CA5B—cardiovascular system—nicotine dependence	0.00323	0.0201	CbGeAlD
Topiramate—Sexual dysfunction—Varenicline—nicotine dependence	0.00323	0.00733	CcSEcCtD
Topiramate—Suicide attempt—Varenicline—nicotine dependence	0.00319	0.00724	CcSEcCtD
Topiramate—SCN5A—cardiovascular system—nicotine dependence	0.00313	0.0195	CbGeAlD
Topiramate—Completed suicide—Varenicline—nicotine dependence	0.00308	0.00699	CcSEcCtD
Topiramate—Urine analysis abnormal—Varenicline—nicotine dependence	0.00308	0.00699	CcSEcCtD
Topiramate—SCN1A—midbrain—nicotine dependence	0.00304	0.0189	CbGeAlD
Topiramate—GRIK2—midbrain—nicotine dependence	0.00301	0.0187	CbGeAlD
Topiramate—Vaginal discharge—Varenicline—nicotine dependence	0.00297	0.00675	CcSEcCtD
Topiramate—Toothache—Varenicline—nicotine dependence	0.00297	0.00675	CcSEcCtD
Topiramate—Libido increased—Varenicline—nicotine dependence	0.00297	0.00675	CcSEcCtD
Topiramate—CA1—cardiovascular system—nicotine dependence	0.00285	0.0177	CbGeAlD
Topiramate—Parosmia—Varenicline—nicotine dependence	0.00279	0.00633	CcSEcCtD
Topiramate—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00276	0.00627	CcSEcCtD
Topiramate—Upset stomach—Varenicline—nicotine dependence	0.00276	0.00627	CcSEcCtD
Topiramate—CA7—brain—nicotine dependence	0.00272	0.0169	CbGeAlD
Topiramate—Menstrual disorder—Varenicline—nicotine dependence	0.00265	0.00603	CcSEcCtD
Topiramate—Paranoia—Varenicline—nicotine dependence	0.00265	0.00603	CcSEcCtD
Topiramate—GRIA1—brain—nicotine dependence	0.00264	0.0164	CbGeAlD
Topiramate—Suicidal ideation—Varenicline—nicotine dependence	0.00258	0.00586	CcSEcCtD
Topiramate—Delusion—Varenicline—nicotine dependence	0.00256	0.0058	CcSEcCtD
Topiramate—Nystagmus—Varenicline—nicotine dependence	0.00253	0.00575	CcSEcCtD
Topiramate—Hyperlipidaemia—Varenicline—nicotine dependence	0.00251	0.0057	CcSEcCtD
Topiramate—Mania—Varenicline—nicotine dependence	0.00249	0.00565	CcSEcCtD
Topiramate—Menorrhagia—Varenicline—nicotine dependence	0.00244	0.00555	CcSEcCtD
Topiramate—Scotoma—Varenicline—nicotine dependence	0.00238	0.00541	CcSEcCtD
Topiramate—GABRB2—midbrain—nicotine dependence	0.00237	0.0147	CbGeAlD
Topiramate—GABRG2—midbrain—nicotine dependence	0.00237	0.0147	CbGeAlD
Topiramate—Gingivitis—Varenicline—nicotine dependence	0.0023	0.00523	CcSEcCtD
Topiramate—Mydriasis—Varenicline—nicotine dependence	0.00227	0.00515	CcSEcCtD
Topiramate—Nephrolithiasis—Varenicline—nicotine dependence	0.00225	0.00511	CcSEcCtD
Topiramate—Rhinorrhoea—Varenicline—nicotine dependence	0.00223	0.00507	CcSEcCtD
Topiramate—CA4—cardiovascular system—nicotine dependence	0.00223	0.0139	CbGeAlD
Topiramate—Dysphonia—Varenicline—nicotine dependence	0.0022	0.00499	CcSEcCtD
Topiramate—Endocrine disorder—Varenicline—nicotine dependence	0.00218	0.00496	CcSEcCtD
Topiramate—Acne—Varenicline—nicotine dependence	0.00215	0.00488	CcSEcCtD
Topiramate—GRIA2—brain—nicotine dependence	0.00209	0.013	CbGeAlD
Topiramate—GABRA1—midbrain—nicotine dependence	0.00209	0.013	CbGeAlD
Topiramate—Disturbance in attention—Varenicline—nicotine dependence	0.00209	0.00474	CcSEcCtD
Topiramate—Aggression—Varenicline—nicotine dependence	0.00206	0.00468	CcSEcCtD
Topiramate—Viral infection—Varenicline—nicotine dependence	0.002	0.00455	CcSEcCtD
Topiramate—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.002	0.00455	CcSEcCtD
Topiramate—Thinking abnormal—Varenicline—nicotine dependence	0.00198	0.00449	CcSEcCtD
Topiramate—Lacrimation increased—Varenicline—nicotine dependence	0.00196	0.00446	CcSEcCtD
Topiramate—Nocturia—Varenicline—nicotine dependence	0.00195	0.00443	CcSEcCtD
Topiramate—Dysarthria—Varenicline—nicotine dependence	0.00191	0.00434	CcSEcCtD
Topiramate—SCN1A—brain—nicotine dependence	0.00191	0.0119	CbGeAlD
Topiramate—GRIK2—brain—nicotine dependence	0.00189	0.0118	CbGeAlD
Topiramate—CA2—cardiovascular system—nicotine dependence	0.00185	0.0115	CbGeAlD
Topiramate—Coordination abnormal—Varenicline—nicotine dependence	0.00184	0.00418	CcSEcCtD
Topiramate—Musculoskeletal pain—Varenicline—nicotine dependence	0.00183	0.00416	CcSEcCtD
Topiramate—Pulmonary embolism—Varenicline—nicotine dependence	0.00181	0.00411	CcSEcCtD
Topiramate—CA12—brain—nicotine dependence	0.00177	0.011	CbGeAlD
Topiramate—Influenza like illness—Varenicline—nicotine dependence	0.00176	0.00399	CcSEcCtD
Topiramate—Salivary hypersecretion—Varenicline—nicotine dependence	0.00176	0.00399	CcSEcCtD
Topiramate—CA4—midbrain—nicotine dependence	0.00174	0.0108	CbGeAlD
Topiramate—Photophobia—Varenicline—nicotine dependence	0.0017	0.00386	CcSEcCtD
Topiramate—Dry eye—Varenicline—nicotine dependence	0.00167	0.00379	CcSEcCtD
Topiramate—Oesophagitis—Varenicline—nicotine dependence	0.00165	0.00375	CcSEcCtD
Topiramate—GRIK3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00164	0.00411	CbGpPWpGaD
Topiramate—Mouth ulceration—Varenicline—nicotine dependence	0.00164	0.00371	CcSEcCtD
Topiramate—Urine output increased—Varenicline—nicotine dependence	0.00164	0.00371	CcSEcCtD
Topiramate—GRIK1—Neuronal System—GABRA4—nicotine dependence	0.00162	0.00407	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—GABRA4—nicotine dependence	0.00162	0.00407	CbGpPWpGaD
Topiramate—GRIA1—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.00161	0.00403	CbGpPWpGaD
Topiramate—GRIA4—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00161	0.00403	CbGpPWpGaD
Topiramate—CA5B—brain—nicotine dependence	0.00159	0.00985	CbGeAlD
Topiramate—Hypertonia—Varenicline—nicotine dependence	0.00159	0.0036	CcSEcCtD
Topiramate—Mental disability—Varenicline—nicotine dependence	0.00157	0.00356	CcSEcCtD
Topiramate—GRIK1—Neuronal System—CHRNB4—nicotine dependence	0.00156	0.0039	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—CHRNA5—nicotine dependence	0.00156	0.0039	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—CHRNA5—nicotine dependence	0.00156	0.0039	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—CHRNB4—nicotine dependence	0.00156	0.0039	CbGpPWpGaD
Topiramate—Euphoric mood—Varenicline—nicotine dependence	0.00155	0.00353	CcSEcCtD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00155	0.00389	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00154	0.00386	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00154	0.00386	CbGpPWpGaD
Topiramate—Lymphadenopathy—Varenicline—nicotine dependence	0.00154	0.0035	CcSEcCtD
Topiramate—SCN5A—brain—nicotine dependence	0.00154	0.00955	CbGeAlD
Topiramate—GRIA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00153	0.00384	CbGpPWpGaD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00152	0.00382	CbGpPWpGaD
Topiramate—Sleep disorder—Varenicline—nicotine dependence	0.00152	0.00344	CcSEcCtD
Topiramate—Diabetes mellitus—Varenicline—nicotine dependence	0.00151	0.00343	CcSEcCtD
Topiramate—Polyuria—Varenicline—nicotine dependence	0.0015	0.0034	CcSEcCtD
Topiramate—GABRB2—brain—nicotine dependence	0.00149	0.00925	CbGeAlD
Topiramate—GABRG2—brain—nicotine dependence	0.00149	0.00925	CbGeAlD
Topiramate—Disorientation—Varenicline—nicotine dependence	0.00147	0.00333	CcSEcCtD
Topiramate—Deafness—Varenicline—nicotine dependence	0.00147	0.00333	CcSEcCtD
Topiramate—GRIA3—Neuronal System—CHRNB3—nicotine dependence	0.00146	0.00367	CbGpPWpGaD
Topiramate—Eczema—Varenicline—nicotine dependence	0.00146	0.00332	CcSEcCtD
Topiramate—GRIK5—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00146	0.00366	CbGpPWpGaD
Topiramate—GRIK4—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00146	0.00366	CbGpPWpGaD
Topiramate—Eye pain—Varenicline—nicotine dependence	0.00145	0.0033	CcSEcCtD
Topiramate—GRIK3—Neuronal System—CHRNA5—nicotine dependence	0.00145	0.00363	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—CHRNA5—nicotine dependence	0.00145	0.00363	CbGpPWpGaD
Topiramate—CA2—midbrain—nicotine dependence	0.00144	0.00897	CbGeAlD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00144	0.00362	CbGpPWpGaD
Topiramate—Libido decreased—Varenicline—nicotine dependence	0.00142	0.00322	CcSEcCtD
Topiramate—Hot flush—Varenicline—nicotine dependence	0.0014	0.00319	CcSEcCtD
Topiramate—CA1—brain—nicotine dependence	0.0014	0.0087	CbGeAlD
Topiramate—Increased appetite—Varenicline—nicotine dependence	0.0014	0.00317	CcSEcCtD
Topiramate—Amnesia—Varenicline—nicotine dependence	0.0014	0.00317	CcSEcCtD
Topiramate—GRIA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00139	0.00349	CbGpPWpGaD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00139	0.00349	CbGpPWpGaD
Topiramate—Menopausal symptoms—Varenicline—nicotine dependence	0.00139	0.00316	CcSEcCtD
Topiramate—GRIA3—Neuronal System—CHRNA6—nicotine dependence	0.00139	0.00348	CbGpPWpGaD
Topiramate—Visual disturbance—Varenicline—nicotine dependence	0.00139	0.00315	CcSEcCtD
Topiramate—GRIA4—Neuronal System—GABRA4—nicotine dependence	0.00138	0.00346	CbGpPWpGaD
Topiramate—Thirst—Varenicline—nicotine dependence	0.00138	0.00313	CcSEcCtD
Topiramate—GRIK3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00136	0.0034	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00136	0.0034	CbGpPWpGaD
Topiramate—Hypoglycaemia—Varenicline—nicotine dependence	0.00135	0.00306	CcSEcCtD
Topiramate—Lethargy—Varenicline—nicotine dependence	0.00134	0.00304	CcSEcCtD
Topiramate—GRIK4—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00132	0.00332	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00132	0.00332	CbGpPWpGaD
Topiramate—GRIA4—Neuronal System—CHRNB4—nicotine dependence	0.00132	0.00332	CbGpPWpGaD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00132	0.00331	CbGpPWpGaD
Topiramate—GABRA1—brain—nicotine dependence	0.00131	0.00817	CbGeAlD
Topiramate—Osteoarthritis—Varenicline—nicotine dependence	0.00131	0.00298	CcSEcCtD
Topiramate—GRIA3—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00131	0.00328	CbGpPWpGaD
Topiramate—GRIA4—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00131	0.00328	CbGpPWpGaD
Topiramate—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.0013	0.00296	CcSEcCtD
Topiramate—Affect lability—Varenicline—nicotine dependence	0.00129	0.00294	CcSEcCtD
Topiramate—Migraine—Varenicline—nicotine dependence	0.00129	0.00294	CcSEcCtD
Topiramate—Psychotic disorder—Varenicline—nicotine dependence	0.00128	0.00291	CcSEcCtD
Topiramate—GRIK4—Neuronal System—CHRNA3—nicotine dependence	0.00127	0.00318	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—CHRNA3—nicotine dependence	0.00127	0.00318	CbGpPWpGaD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00127	0.00317	CbGpPWpGaD
Topiramate—GRIA3—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00126	0.00315	CbGpPWpGaD
Topiramate—Irritability—Varenicline—nicotine dependence	0.00125	0.00285	CcSEcCtD
Topiramate—Urinary retention—Varenicline—nicotine dependence	0.00125	0.00284	CcSEcCtD
Topiramate—Mood swings—Varenicline—nicotine dependence	0.00124	0.00282	CcSEcCtD
Topiramate—GRIK1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00123	0.00309	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00123	0.00309	CbGpPWpGaD
Topiramate—GRIA4—Neuronal System—CHRNA5—nicotine dependence	0.00123	0.00309	CbGpPWpGaD
Topiramate—Liver function test abnormal—Varenicline—nicotine dependence	0.00121	0.00275	CcSEcCtD
Topiramate—Abdominal pain upper—Varenicline—nicotine dependence	0.0012	0.00272	CcSEcCtD
Topiramate—Hypokalaemia—Varenicline—nicotine dependence	0.00119	0.00271	CcSEcCtD
Topiramate—GABRB2—GABA receptor activation—GABRA4—nicotine dependence	0.00119	0.00299	CbGpPWpGaD
Topiramate—Breast disorder—Varenicline—nicotine dependence	0.00119	0.00269	CcSEcCtD
Topiramate—GRIK1—Neuronal System—CHRNA3—nicotine dependence	0.00118	0.00296	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—CHRNA3—nicotine dependence	0.00118	0.00296	CbGpPWpGaD
Topiramate—Nasopharyngitis—Varenicline—nicotine dependence	0.00117	0.00267	CcSEcCtD
Topiramate—GRIA3—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00117	0.00293	CbGpPWpGaD
Topiramate—Gastritis—Varenicline—nicotine dependence	0.00116	0.00264	CcSEcCtD
Topiramate—GRIA4—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00115	0.00289	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00114	0.00287	CbGpPWpGaD
Topiramate—Abdominal distension—Varenicline—nicotine dependence	0.00114	0.00259	CcSEcCtD
Topiramate—Dysphagia—Varenicline—nicotine dependence	0.00113	0.00258	CcSEcCtD
Topiramate—Asthma—Varenicline—nicotine dependence	0.00113	0.00258	CcSEcCtD
Topiramate—GRIA2—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.00112	0.00282	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—CHRNB2—nicotine dependence	0.00112	0.0028	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—CHRNB2—nicotine dependence	0.00112	0.0028	CbGpPWpGaD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00111	0.00279	CbGpPWpGaD
Topiramate—Angina pectoris—Varenicline—nicotine dependence	0.00111	0.00251	CcSEcCtD
Topiramate—CA4—brain—nicotine dependence	0.00109	0.0068	CbGeAlD
Topiramate—Bronchitis—Varenicline—nicotine dependence	0.00109	0.00248	CcSEcCtD
Topiramate—GABRG2—GABA receptor activation—GABRA4—nicotine dependence	0.00109	0.00273	CbGpPWpGaD
Topiramate—Abdominal discomfort—Varenicline—nicotine dependence	0.00109	0.00247	CcSEcCtD
Topiramate—GRIA1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00108	0.00272	CbGpPWpGaD
Topiramate—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00107	0.00268	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00106	0.00267	CbGpPWpGaD
Topiramate—Pollakiuria—Varenicline—nicotine dependence	0.00105	0.00238	CcSEcCtD
Topiramate—GRIK2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00105	0.00262	CbGpPWpGaD
Topiramate—GRIA4—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00105	0.00262	CbGpPWpGaD
Topiramate—Erectile dysfunction—Varenicline—nicotine dependence	0.00105	0.00237	CcSEcCtD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00104	0.00262	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—CHRNB2—nicotine dependence	0.00104	0.0026	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—CHRNB2—nicotine dependence	0.00104	0.0026	CbGpPWpGaD
Topiramate—Photosensitivity reaction—Varenicline—nicotine dependence	0.00104	0.00235	CcSEcCtD
Topiramate—Weight increased—Varenicline—nicotine dependence	0.00103	0.00235	CcSEcCtD
Topiramate—Hyperglycaemia—Varenicline—nicotine dependence	0.00102	0.00232	CcSEcCtD
Topiramate—GRIK5—Neuronal System—CHRNA4—nicotine dependence	0.00101	0.00254	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—CHRNA4—nicotine dependence	0.00101	0.00254	CbGpPWpGaD
Topiramate—Infestation NOS—Varenicline—nicotine dependence	0.00101	0.0023	CcSEcCtD
Topiramate—Infestation—Varenicline—nicotine dependence	0.00101	0.0023	CcSEcCtD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00101	0.00254	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00101	0.00253	CbGpPWpGaD
Topiramate—Depression—Varenicline—nicotine dependence	0.00101	0.00229	CcSEcCtD
Topiramate—GRIA3—Neuronal System—GABRA4—nicotine dependence	0.001	0.00252	CbGpPWpGaD
Topiramate—GRIA4—Neuronal System—CHRNA3—nicotine dependence	0.001	0.00252	CbGpPWpGaD
Topiramate—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.001	0.00228	CcSEcCtD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.001	0.00251	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.000992	0.00249	CbGpPWpGaD
Topiramate—Stomatitis—Varenicline—nicotine dependence	0.000986	0.00224	CcSEcCtD
Topiramate—Conjunctivitis—Varenicline—nicotine dependence	0.000983	0.00223	CcSEcCtD
Topiramate—GRIA3—Neuronal System—CHRNB4—nicotine dependence	0.000962	0.00241	CbGpPWpGaD
Topiramate—Epistaxis—Varenicline—nicotine dependence	0.000954	0.00217	CcSEcCtD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.000954	0.00239	CbGpPWpGaD
Topiramate—GABRA1—GABA receptor activation—GABRA4—nicotine dependence	0.000953	0.00239	CbGpPWpGaD
Topiramate—GRIA3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000951	0.00239	CbGpPWpGaD
Topiramate—Sinusitis—Varenicline—nicotine dependence	0.000949	0.00216	CcSEcCtD
Topiramate—GRIK3—Neuronal System—CHRNA4—nicotine dependence	0.000943	0.00236	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—CHRNA4—nicotine dependence	0.000943	0.00236	CbGpPWpGaD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00093	0.00233	CbGpPWpGaD
Topiramate—Bradycardia—Varenicline—nicotine dependence	0.000925	0.0021	CcSEcCtD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.000915	0.00229	CbGpPWpGaD
Topiramate—CA2—brain—nicotine dependence	0.000907	0.00564	CbGeAlD
Topiramate—Hallucination—Varenicline—nicotine dependence	0.000904	0.00205	CcSEcCtD
Topiramate—Hypoaesthesia—Varenicline—nicotine dependence	0.000904	0.00205	CcSEcCtD
Topiramate—Urinary tract disorder—Varenicline—nicotine dependence	0.000897	0.00204	CcSEcCtD
Topiramate—Oedema peripheral—Varenicline—nicotine dependence	0.000895	0.00203	CcSEcCtD
Topiramate—GRIA3—Neuronal System—CHRNA5—nicotine dependence	0.000894	0.00224	CbGpPWpGaD
Topiramate—Connective tissue disorder—Varenicline—nicotine dependence	0.000892	0.00203	CcSEcCtD
Topiramate—Urethral disorder—Varenicline—nicotine dependence	0.00089	0.00202	CcSEcCtD
Topiramate—GRIA4—Neuronal System—CHRNB2—nicotine dependence	0.000883	0.00221	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—CHRNB3—nicotine dependence	0.000877	0.0022	CbGpPWpGaD
Topiramate—Visual impairment—Varenicline—nicotine dependence	0.000875	0.00199	CcSEcCtD
Topiramate—Erythema multiforme—Varenicline—nicotine dependence	0.000859	0.00195	CcSEcCtD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.000851	0.00213	CbGpPWpGaD
Topiramate—Eye disorder—Varenicline—nicotine dependence	0.000849	0.00193	CcSEcCtD
Topiramate—Tinnitus—Varenicline—nicotine dependence	0.000847	0.00192	CcSEcCtD
Topiramate—Cardiac disorder—Varenicline—nicotine dependence	0.000843	0.00191	CcSEcCtD
Topiramate—GRIA3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000838	0.0021	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—CHRNA6—nicotine dependence	0.000831	0.00208	CbGpPWpGaD
Topiramate—Angiopathy—Varenicline—nicotine dependence	0.000824	0.00187	CcSEcCtD
Topiramate—Immune system disorder—Varenicline—nicotine dependence	0.00082	0.00186	CcSEcCtD
Topiramate—Mediastinal disorder—Varenicline—nicotine dependence	0.000819	0.00186	CcSEcCtD
Topiramate—Chills—Varenicline—nicotine dependence	0.000815	0.00185	CcSEcCtD
Topiramate—GRIK2—Neuronal System—CHRNB3—nicotine dependence	0.000802	0.00201	CbGpPWpGaD
Topiramate—GRIA4—Neuronal System—CHRNA4—nicotine dependence	0.000802	0.00201	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0008	0.00201	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.0008	0.00201	CbGpPWpGaD
Topiramate—Mental disorder—Varenicline—nicotine dependence	0.000796	0.00181	CcSEcCtD
Topiramate—Malnutrition—Varenicline—nicotine dependence	0.000791	0.0018	CcSEcCtD
Topiramate—Erythema—Varenicline—nicotine dependence	0.000791	0.0018	CcSEcCtD
Topiramate—GRIA1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000784	0.00197	CbGpPWpGaD
Topiramate—Flatulence—Varenicline—nicotine dependence	0.000779	0.00177	CcSEcCtD
Topiramate—Dysgeusia—Varenicline—nicotine dependence	0.000774	0.00176	CcSEcCtD
Topiramate—Back pain—Varenicline—nicotine dependence	0.000765	0.00174	CcSEcCtD
Topiramate—GRIA3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00076	0.00191	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—CHRNA6—nicotine dependence	0.00076	0.00191	CbGpPWpGaD
Topiramate—Muscle spasms—Varenicline—nicotine dependence	0.00076	0.00173	CcSEcCtD
Topiramate—GRIA2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.000759	0.0019	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.000758	0.0019	CbGpPWpGaD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.000758	0.0019	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000752	0.00189	CbGpPWpGaD
Topiramate—Vision blurred—Varenicline—nicotine dependence	0.000745	0.00169	CcSEcCtD
Topiramate—Tremor—Varenicline—nicotine dependence	0.000741	0.00168	CcSEcCtD
Topiramate—Ill-defined disorder—Varenicline—nicotine dependence	0.000734	0.00167	CcSEcCtD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.000731	0.00183	CbGpPWpGaD
Topiramate—Anaemia—Varenicline—nicotine dependence	0.000731	0.00166	CcSEcCtD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00073	0.00183	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—CHRNA3—nicotine dependence	0.000729	0.00183	CbGpPWpGaD
Topiramate—Agitation—Varenicline—nicotine dependence	0.000727	0.00165	CcSEcCtD
Topiramate—GRIK2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000717	0.0018	CbGpPWpGaD
Topiramate—Malaise—Varenicline—nicotine dependence	0.000713	0.00162	CcSEcCtD
Topiramate—Vertigo—Varenicline—nicotine dependence	0.00071	0.00161	CcSEcCtD
Topiramate—Syncope—Varenicline—nicotine dependence	0.000709	0.00161	CcSEcCtD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.0007	0.00175	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000699	0.00175	CbGpPWpGaD
Topiramate—Palpitations—Varenicline—nicotine dependence	0.000699	0.00159	CcSEcCtD
Topiramate—GABRB2—Orphan transporters—GABRA4—nicotine dependence	0.000695	0.00174	CbGpPWpGaD
Topiramate—Loss of consciousness—Varenicline—nicotine dependence	0.000695	0.00158	CcSEcCtD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.000693	0.00174	CbGpPWpGaD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.000693	0.00174	CbGpPWpGaD
Topiramate—Cough—Varenicline—nicotine dependence	0.00069	0.00157	CcSEcCtD
Topiramate—GRIK2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000688	0.00172	CbGpPWpGaD
Topiramate—Convulsion—Varenicline—nicotine dependence	0.000685	0.00156	CcSEcCtD
Topiramate—Hypertension—Varenicline—nicotine dependence	0.000683	0.00155	CcSEcCtD
Topiramate—Arthralgia—Varenicline—nicotine dependence	0.000673	0.00153	CcSEcCtD
Topiramate—Myalgia—Varenicline—nicotine dependence	0.000673	0.00153	CcSEcCtD
Topiramate—Chest pain—Varenicline—nicotine dependence	0.000673	0.00153	CcSEcCtD
Topiramate—Anxiety—Varenicline—nicotine dependence	0.000671	0.00152	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.000668	0.00152	CcSEcCtD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.000667	0.00167	CbGpPWpGaD
Topiramate—Discomfort—Varenicline—nicotine dependence	0.000665	0.00151	CcSEcCtD
Topiramate—Dry mouth—Varenicline—nicotine dependence	0.000658	0.0015	CcSEcCtD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00065	0.00163	CbGpPWpGaD
Topiramate—Oedema—Varenicline—nicotine dependence	0.000645	0.00147	CcSEcCtD
Topiramate—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.000642	0.00161	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—CHRNB2—nicotine dependence	0.000642	0.00161	CbGpPWpGaD
Topiramate—Infection—Varenicline—nicotine dependence	0.000641	0.00146	CcSEcCtD
Topiramate—GRIK2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000639	0.0016	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.000639	0.0016	CbGpPWpGaD
Topiramate—GABRG2—Orphan transporters—GABRA4—nicotine dependence	0.000636	0.00159	CbGpPWpGaD
Topiramate—Shock—Varenicline—nicotine dependence	0.000635	0.00144	CcSEcCtD
Topiramate—Nervous system disorder—Varenicline—nicotine dependence	0.000633	0.00144	CcSEcCtD
Topiramate—Thrombocytopenia—Varenicline—nicotine dependence	0.000632	0.00143	CcSEcCtD
Topiramate—Tachycardia—Varenicline—nicotine dependence	0.00063	0.00143	CcSEcCtD
Topiramate—Skin disorder—Varenicline—nicotine dependence	0.000627	0.00142	CcSEcCtD
Topiramate—Hyperhidrosis—Varenicline—nicotine dependence	0.000624	0.00142	CcSEcCtD
Topiramate—Anorexia—Varenicline—nicotine dependence	0.000615	0.0014	CcSEcCtD
Topiramate—GRIA2—Neuronal System—CHRNB3—nicotine dependence	0.000613	0.00154	CbGpPWpGaD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00061	0.00153	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.000606	0.00152	CbGpPWpGaD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000606	0.00152	CbGpPWpGaD
Topiramate—Hypotension—Varenicline—nicotine dependence	0.000603	0.00137	CcSEcCtD
Topiramate—GABRB2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.000601	0.00151	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—GABRA4—nicotine dependence	0.000601	0.00151	CbGpPWpGaD
Topiramate—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000588	0.00134	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000585	0.00147	CbGpPWpGaD
Topiramate—Insomnia—Varenicline—nicotine dependence	0.000584	0.00133	CcSEcCtD
Topiramate—GRIA3—Neuronal System—CHRNA4—nicotine dependence	0.000583	0.00146	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—CHRNA6—nicotine dependence	0.000581	0.00146	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—CHRNB4—nicotine dependence	0.000576	0.00144	CbGpPWpGaD
Topiramate—Dyspnoea—Varenicline—nicotine dependence	0.000575	0.00131	CcSEcCtD
Topiramate—Somnolence—Varenicline—nicotine dependence	0.000574	0.0013	CcSEcCtD
Topiramate—GABRB2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00057	0.00143	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00057	0.00143	CbGpPWpGaD
Topiramate—Dyspepsia—Varenicline—nicotine dependence	0.000568	0.00129	CcSEcCtD
Topiramate—Decreased appetite—Varenicline—nicotine dependence	0.000561	0.00127	CcSEcCtD
Topiramate—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000557	0.00127	CcSEcCtD
Topiramate—Fatigue—Varenicline—nicotine dependence	0.000556	0.00126	CcSEcCtD
Topiramate—GABRA1—Orphan transporters—GABRA4—nicotine dependence	0.000556	0.00139	CbGpPWpGaD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000554	0.00139	CbGpPWpGaD
Topiramate—Constipation—Varenicline—nicotine dependence	0.000552	0.00125	CcSEcCtD
Topiramate—Pain—Varenicline—nicotine dependence	0.000552	0.00125	CcSEcCtD
Topiramate—GABRG2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00055	0.00138	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—GABRA4—nicotine dependence	0.00055	0.00138	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000549	0.00138	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.000548	0.00137	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—CHRNA5—nicotine dependence	0.000536	0.00134	CbGpPWpGaD
Topiramate—Feeling abnormal—Varenicline—nicotine dependence	0.000532	0.00121	CcSEcCtD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00053	0.00133	CbGpPWpGaD
Topiramate—Gastrointestinal pain—Varenicline—nicotine dependence	0.000528	0.0012	CcSEcCtD
Topiramate—GRIK2—Neuronal System—CHRNB4—nicotine dependence	0.000527	0.00132	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000526	0.00132	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.000525	0.00132	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.000521	0.00131	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000521	0.00131	CbGpPWpGaD
Topiramate—Urticaria—Varenicline—nicotine dependence	0.000513	0.00116	CcSEcCtD
Topiramate—Abdominal pain—Varenicline—nicotine dependence	0.00051	0.00116	CcSEcCtD
Topiramate—Body temperature increased—Varenicline—nicotine dependence	0.00051	0.00116	CcSEcCtD
Topiramate—GRIA1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000502	0.00126	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.000501	0.00126	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—CHRNA5—nicotine dependence	0.00049	0.00123	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000489	0.00123	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.000488	0.00122	CbGpPWpGaD
Topiramate—GABRB2—Ion channel transport—GABRA4—nicotine dependence	0.000488	0.00122	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.000481	0.0012	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.000481	0.0012	CbGpPWpGaD
Topiramate—Hypersensitivity—Varenicline—nicotine dependence	0.000475	0.00108	CcSEcCtD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.000467	0.00117	CbGpPWpGaD
Topiramate—Asthenia—Varenicline—nicotine dependence	0.000463	0.00105	CcSEcCtD
Topiramate—GABRB2—Neuronal System—CHRNB3—nicotine dependence	0.000461	0.00115	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000459	0.00115	CbGpPWpGaD
Topiramate—Pruritus—Varenicline—nicotine dependence	0.000457	0.00104	CcSEcCtD
Topiramate—GABRA1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.000456	0.00114	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000456	0.00114	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.000447	0.00112	CbGpPWpGaD
Topiramate—GABRG2—Ion channel transport—GABRA4—nicotine dependence	0.000446	0.00112	CbGpPWpGaD
Topiramate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000443	0.00111	CbGpPWpGaD
Topiramate—Diarrhoea—Varenicline—nicotine dependence	0.000441	0.001	CcSEcCtD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.000438	0.0011	CbGpPWpGaD
Topiramate—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000438	0.0011	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—CHRNA6—nicotine dependence	0.000437	0.00109	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—CHRNA3—nicotine dependence	0.000437	0.00109	CbGpPWpGaD
Topiramate—Dizziness—Varenicline—nicotine dependence	0.000427	0.000969	CcSEcCtD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000424	0.00106	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—CHRNB3—nicotine dependence	0.000421	0.00106	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—GABRA4—nicotine dependence	0.00042	0.00105	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00042	0.00105	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000417	0.00104	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000412	0.00103	CbGpPWpGaD
Topiramate—Vomiting—Varenicline—nicotine dependence	0.00041	0.000932	CcSEcCtD
Topiramate—Rash—Varenicline—nicotine dependence	0.000407	0.000924	CcSEcCtD
Topiramate—Dermatitis—Varenicline—nicotine dependence	0.000406	0.000923	CcSEcCtD
Topiramate—Headache—Varenicline—nicotine dependence	0.000404	0.000918	CcSEcCtD
Topiramate—GRIA2—Neuronal System—CHRNB4—nicotine dependence	0.000403	0.00101	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—CHRNA6—nicotine dependence	0.000399	0.001	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—CHRNA3—nicotine dependence	0.000399	0.001	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000399	0.000999	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.000398	0.000998	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000395	0.00099	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.000391	0.000979	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00039	0.000978	CbGpPWpGaD
Topiramate—GABRA1—Ion channel transport—GABRA4—nicotine dependence	0.00039	0.000978	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000385	0.000966	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—CHRNB2—nicotine dependence	0.000384	0.000964	CbGpPWpGaD
Topiramate—Nausea—Varenicline—nicotine dependence	0.000383	0.000871	CcSEcCtD
Topiramate—GABRG2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000377	0.000945	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—CHRNA5—nicotine dependence	0.000375	0.000939	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—CHRNB3—nicotine dependence	0.000368	0.000923	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000367	0.000921	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.000364	0.000913	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000361	0.000906	CbGpPWpGaD
Topiramate—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00036	0.000901	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000354	0.000888	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—CHRNB2—nicotine dependence	0.000352	0.000882	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000351	0.00088	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.000351	0.000879	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—CHRNA6—nicotine dependence	0.000349	0.000875	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—CHRNA4—nicotine dependence	0.000349	0.000875	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000336	0.000842	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000329	0.000826	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.000321	0.000804	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—CHRNA4—nicotine dependence	0.000319	0.000801	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000319	0.000799	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000318	0.000798	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.000318	0.000798	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000316	0.000792	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—GABRA4—nicotine dependence	0.000316	0.000792	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—CHRNA3—nicotine dependence	0.000305	0.000766	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—CHRNB4—nicotine dependence	0.000303	0.000759	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000299	0.000751	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000294	0.000736	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000291	0.00073	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—GABRA4—nicotine dependence	0.000289	0.000724	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—CHRNA5—nicotine dependence	0.000281	0.000705	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00028	0.000703	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—CHRNB4—nicotine dependence	0.000277	0.000694	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000274	0.000687	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—CHRNB2—nicotine dependence	0.000269	0.000674	CbGpPWpGaD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000267	0.000669	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000264	0.000661	CbGpPWpGaD
Topiramate—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000263	0.00066	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—CHRNA5—nicotine dependence	0.000257	0.000645	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000257	0.000644	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000255	0.000638	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—GABRA4—nicotine dependence	0.000252	0.000633	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—CHRNA4—nicotine dependence	0.000244	0.000612	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—CHRNB4—nicotine dependence	0.000242	0.000607	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000241	0.000604	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000239	0.0006	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000239	0.0006	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000233	0.000585	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—CHRNA3—nicotine dependence	0.000229	0.000575	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—CHRNA5—nicotine dependence	0.000225	0.000564	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000219	0.000549	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000216	0.000542	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000211	0.000528	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—CHRNA3—nicotine dependence	0.00021	0.000526	CbGpPWpGaD
Topiramate—CA6—Metabolism—CYP2A7—nicotine dependence	0.000209	0.000525	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CYP2A7—nicotine dependence	0.000209	0.000525	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000203	0.000508	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—CHRNB2—nicotine dependence	0.000202	0.000506	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYP2A7—nicotine dependence	0.000195	0.00049	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP2A7—nicotine dependence	0.000195	0.00049	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000191	0.00048	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000191	0.000479	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000188	0.000472	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—CHRNB2—nicotine dependence	0.000185	0.000463	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—CHRNA4—nicotine dependence	0.000183	0.00046	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—CHRNA3—nicotine dependence	0.000183	0.00046	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYP2A7—nicotine dependence	0.000181	0.000454	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00017	0.000426	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—CHRNA4—nicotine dependence	0.000168	0.000421	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—CHRNB2—nicotine dependence	0.000161	0.000405	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000155	0.000389	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—CHRNA4—nicotine dependence	0.000147	0.000368	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP2A7—nicotine dependence	0.000144	0.000362	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP2A7—nicotine dependence	0.000138	0.000347	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000136	0.00034	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP2A7—nicotine dependence	0.000133	0.000333	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000122	0.000305	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP2A7—nicotine dependence	0.000117	0.000293	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000115	0.000288	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000113	0.000284	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP2A7—nicotine dependence	3.27e-05	8.19e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP2A7—nicotine dependence	1.96e-05	4.92e-05	CbGpPWpGaD
